Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

Katsuyuki Ando; Masakazu Haneda; Sadayoshi Ito; Naoki Kashihara; Koichi Node; Masaomi Nangaku; Tatsuo Shimosawa; Junji Kishimoto; Toshiro Fujita

doi:10.1007/s10557-011-6315-7

Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

Katsuyuki Ando, Masakazu Haneda, Sadayoshi Ito, Naoki Kashihara, Koichi Node, Masaomi Nangaku, Tatsuo Shimosawa, Junji Kishimoto, Toshiro Fujita

Center for Clinical and Translational Research(CCTR)

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	365-366
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	25
Issue number	4
DOIs	https://doi.org/10.1007/s10557-011-6315-7
Publication status	Published - Aug 2011

All Science Journal Classification (ASJC) codes

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10557-011-6315-7

Cite this

Ando, K., Haneda, M., Ito, S., Kashihara, N., Node, K., Nangaku, M., Shimosawa, T., Kishimoto, J., & Fujita, T. (2011). Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). Cardiovascular Drugs and Therapy, 25(4), 365-366. https://doi.org/10.1007/s10557-011-6315-7

Erratum : Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). / Ando, Katsuyuki; Haneda, Masakazu; Ito, Sadayoshi et al.

In: Cardiovascular Drugs and Therapy, Vol. 25, No. 4, 08.2011, p. 365-366.

Research output: Contribution to journal › Comment/debate › peer-review

Ando, K, Haneda, M, Ito, S, Kashihara, N, Node, K, Nangaku, M, Shimosawa, T, Kishimoto, J & Fujita, T 2011, 'Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))', Cardiovascular Drugs and Therapy, vol. 25, no. 4, pp. 365-366. https://doi.org/10.1007/s10557-011-6315-7

Ando K, Haneda M, Ito S, Kashihara N, Node K, Nangaku M et al. Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). Cardiovascular Drugs and Therapy. 2011 Aug;25(4):365-366. doi: 10.1007/s10557-011-6315-7

Ando, Katsuyuki ; Haneda, Masakazu ; Ito, Sadayoshi et al. / Erratum : Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5)). In: Cardiovascular Drugs and Therapy. 2011 ; Vol. 25, No. 4. pp. 365-366.

@article{4ecf708e6ee646cbad3dd25dc4ce8942,

title = "Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))",

author = "Katsuyuki Ando and Masakazu Haneda and Sadayoshi Ito and Naoki Kashihara and Koichi Node and Masaomi Nangaku and Tatsuo Shimosawa and Junji Kishimoto and Toshiro Fujita",

year = "2011",

month = aug,

doi = "10.1007/s10557-011-6315-7",

language = "English",

volume = "25",

pages = "365--366",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "4",

}

TY - JOUR

T1 - Erratum

T2 - Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))

AU - Ando, Katsuyuki

AU - Haneda, Masakazu

AU - Ito, Sadayoshi

AU - Kashihara, Naoki

AU - Node, Koichi

AU - Nangaku, Masaomi

AU - Shimosawa, Tatsuo

AU - Kishimoto, Junji

AU - Fujita, Toshiro

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=80052280847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052280847&partnerID=8YFLogxK

U2 - 10.1007/s10557-011-6315-7

DO - 10.1007/s10557-011-6315-7

M3 - Comment/debate

AN - SCOPUS:80052280847

SN - 0920-3206

VL - 25

SP - 365

EP - 366

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 4

ER -

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this